Cryptococcus neoformans Is Resistant to Surfactant Protein A Mediated Host Defense Mechanisms
2007

Cryptococcus neoformans and Surfactant Protein A

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Giles Steven S., Zaas Aimee K., Reidy Mike F., Perfect John R., Wright Jo Rae

Primary Institution: Duke University Medical Center

Hypothesis

Does surfactant protein A (SP-A) mediate host defense against the pulmonary pathogen Cryptococcus neoformans?

Conclusion

The study found that SP-A does not significantly affect the immune response or disease progression in mice infected with C. neoformans.

Supporting Evidence

  • SP-A does not bind to fully encapsulated strains of C. neoformans.
  • SP-A binding was detected when C. neoformans was incubated in bronchoalveolar fluid.
  • SP-A inhibits IgG-mediated phagocytosis of C. neoformans by alveolar macrophages.

Takeaway

The study shows that a protein called SP-A doesn't help the body fight off a fungus called C. neoformans, which can cause serious lung infections.

Methodology

The study used in vitro binding assays and an intranasal infection model in mice to assess the role of SP-A in host defense against C. neoformans.

Limitations

The study primarily focused on a single strain of C. neoformans and may not generalize to other strains or conditions.

Participant Demographics

Mice used in the study included SP-A deficient and wild-type strains.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001370

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication